New promises and challenges in the treatment of advanced non-small-cell lung cancer.
May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares...
https://pubmed.ncbi.nlm.nih.gov/39121882/Actively Recruiting
Led by Peking University People's Hospital · Updated on 2026-08-31
4800
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the clinical validation of a pre-trained and fine-tuned Time-Series Electronic Health Record EHR Foundation Model designed to analyze ICU patient data. This observational study aims to test the models ability to provide accurate and dynamic prognostic support, such as predicting 28-day mortality, in the real-world clinical setting of Peking University Peoples Hospital. The study combines retrospective and prospective cohort designs to assess the models generalization and predictive performance. Participants include ICU patients aged 18 years and older with stays of at least 24 hours and complete electronic health records. The study identifies two groups those who survive beyond 28 days and those who do not, with outcomes obtained from hospital records or telephone follow-ups if hospital stays are short. This approach allows researchers to evaluate the models prognostic accuracy in actual clinical practice. During the study, participants electronic health data, including demographics and laboratory tests, are collected and monitored. Outcomes such as in-hospital mortality and discharge status are recorded, with follow-up calls made when necessary to confirm 28-day survival. The research team measures how well the EHR foundation model predicts these outcomes to support clinical decision-making in critical care settings. The study is scheduled to continue through December 2027.
CONDITIONS
Clinical Validation of a Pre-trained and Fine-tuned Model for Analyzing Time-Series Electronic Health Records in Critical Care
H
Huiying Zhao, PhD
X
Xiaojiang Liu, M.Med
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Peking University People's Hospital
Lead Sponsor
Peking University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote consent and eligibility check)
Duration - Duration of ICU stay plus 28 days follow-up
Participants' electronic health records and laboratory data from ICU stays are collected and monitored. If the hospital stay is short, telephone follow-ups are conducted to gather outcome information.
Hospital data monitoring and possible telephone follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares...
https://pubmed.ncbi.nlm.nih.gov/39121882/Junde Chen, Trudi Di Qi, Jacqueline Vu...
https://pubmed.ncbi.nlm.nih.gov/37852346/Qingqing Mao, Melissa Jay, Jana L Hoffman...
https://pubmed.ncbi.nlm.nih.gov/29374661/Vicki A Jackson, Linda Emanuel
https://pubmed.ncbi.nlm.nih.gov/38118003/Lameck Mbangula Amugongo, Pietro Mascheroni, Steven Brooks...
https://pubmed.ncbi.nlm.nih.gov/40498738/Peking University People's Hospital
Lead Sponsor
Peking University
Collaborating Sponsor